# Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases

> **NCT07252804** · PHASE4 · RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 263 (estimated)

## Conditions studied

- Autoimmune Rheumatologic Disease

## Interventions

- **BIOLOGICAL:** Meningococcal B (Bexsero)

## Key facts

- **NCT ID:** NCT07252804
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-19
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 263 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07252804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07252804, "Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07252804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*